MYREXIS, INC. Executive Severance and Change in Control AgreementExecutive Severance and Change in Control Agreement • September 28th, 2011 • Myrexis, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledSeptember 28th, 2011 Company Industry JurisdictionTHIS EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this “Agreement”), by and between Myrexis, Inc., a Delaware corporation (the “Company”), and Andrea Kendell (the “Executive”), is made as of September 22, 2011 (the “Effective Date”).
MYRIAD PHARMACEUTICALS, INC. Form of Executive Severance and Change in Control AgreementExecutive Severance and Change in Control Agreement • February 4th, 2010 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledFebruary 4th, 2010 Company Industry JurisdictionTHIS EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this “Agreement”), by and between Myriad Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Executive”), is made as of February 1, 2010 (the “Effective Date”).
MYRIAD PHARMACEUTICALS, INC. Executive Severance and Change in Control AgreementExecutive Severance and Change in Control Agreement • February 4th, 2010 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledFebruary 4th, 2010 Company Industry JurisdictionTHIS EXECUTIVE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this “Agreement”), by and between Myriad Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Adrian N. Hobden (the “Executive”), is made as of February 1, 2010 (the “Effective Date”).